Periodic Limb Movement Syndrome in Patients With Cerebral Small Vessel Disease.
NCT04569643 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2021-02-21
Summary
Patients from 60 to 75 years old diagnosed with cerebral small vessel disease with no history of symptomatic stroke, brain tumor, traumatic brain injury, seizures and neurodegenerative or mental disorder will undergo overnight leg actigraphy and cardiorespiratory monitoring. Those of them with apnea/hypopnea index under 5 will be enrolled. Brain MRI and cognitive assessment will be performed at baseline and in 1-year follow-up, sleep quality will be assessed at baseline with self-reported questionnaires. Progression of cerebral small vessel disease markers and cognitive dysfunction will be compared between patients with high periodic limb movement index (the number of periodic limb movement ≥ 15 per hour of sleep) and controls (periodic limb movement index \< 15/h).
Conditions
- Periodic Limb Movement Disorder
- Cerebral Small Vessel Diseases
- Cognitive Dysfunction
Interventions
- DIAGNOSTIC_TEST
-
Actigraphy
Participants will undergo overnight leg actigraphy at baseline. Leg movements will be recorded bilaterally by actigraphic method with two ankle-worn recorders.
- DIAGNOSTIC_TEST
-
Cardiorespiratory monitoring
All participants will be scanned for presence of sleep-related breathing disorders with a portable monitoring device at baseline. The compact screening device will be attached to the patient's wrist during the night sleep.
- DIAGNOSTIC_TEST
-
Neuroimaging
All subjects will undergo brain MRI scanning at baseline and in 1-year follow-up. The imaging protocol will include axial T1, T2, T2\*, FLAIR and diffusion-weighted imaging scans that will be made on a 3-Tesla scanner.
- OTHER
-
Assessment of cognitive function
Assessment will take place at weeks 0 (baseline) and 52 (1 year follow-up). The neuropsychological protocol will be consist of Montreal Cognitive Assessment (MoCA), 12-word Verbal Memory Test, Benton Visual Retention Test, Frontal Assessment Battery, Trail Making Test (parts A and B), phonetic (as a part of the MoCA) and semantic verbal fluency assessment, Symbol Digit Modalities Test.
- OTHER
-
Sleep quality and mood questionnaires
Self-reporting scales and questionnaires will be used at baseline to assess sleep quality, daytime functioning and mood. The protocol includes the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the Geriatric Depression Scale.
Sponsors & Collaborators
-
I.M. Sechenov First Moscow State Medical University
lead OTHER
Principal Investigators
-
Ekaterina D. Spektor, M.D. · I.M. Sechenov First Moscow State Medical University (Sechenov University)
Eligibility
- Min Age
- 60 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-01
- Primary Completion
- 2022-04-30
- Completion
- 2022-08-31
Countries
- Russia
Study Locations
More Related Trials
-
Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders
NCT05486806 ·Status: UNKNOWN
-
Effects of Exercise on Long-Range Autocorrelations in Parkinson's Disease
NCT02419768 ·Status: UNKNOWN ·Phase: NA
-
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
NCT01469741 ·Status: COMPLETED ·Phase: NA
-
Effect of Multimodal Exercise Training on Walking Economy in Individuals With Parkinson's Disease
NCT03864393 ·Status: COMPLETED ·Phase: NA
-
Application of Tremor Analysis in Parkinson's Disease and Its Related Diseases
NCT04970745 ·Status: COMPLETED
-
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
NCT04046276 ·Status: UNKNOWN ·Phase: NA
-
Parkinson Disease Before and After Medication and Rehabilitation Treatment
NCT02672943 ·Status: UNKNOWN ·Phase: NA
-
Development of Cognitive Assessment Tools in Parkinson Disease
NCT00556764 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mindfulness-Enhanced Dual-Task Training in PD-MCI
NCT06930742 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Yoga Training and Retinal Vasculature With Parkinson's Disease
NCT06194227 ·Status: COMPLETED ·Phase: NA
-
The Cyclical Lower-extremity Exercise for Parkinson's Trial
NCT01636297 ·Status: COMPLETED ·Phase: NA
-
Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease
NCT00737217 ·Status: COMPLETED
-
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
NCT04453995 ·Status: UNKNOWN
-
Safety Study to Autonomic Rehabilitation o Parkinson's Disease
NCT02680522 ·Status: COMPLETED ·Phase: NA
-
Physical Therapy and Cognitive Decline
NCT04012086 ·Status: COMPLETED ·Phase: NA
-
Agility Training in Parkinson's Disease
NCT03189680 ·Status: COMPLETED ·Phase: NA
-
Everyday Memory Impairment in PD-related Cognitive Decline
NCT04474379 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Expiratory Muscle Training in Parkinson's Disease With Forward Trunk Flexion
NCT07268703 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Measurement of Nocturnal Hypokinesia in Parkinson's Disease (PD) Patient Compared With Spouse by Wearable Sensors
NCT02352727 ·Status: UNKNOWN
-
Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai
NCT04023201 ·Status: UNKNOWN
-
Non-invasive Assessment of Synaptic Plasticity
NCT05353517 ·Status: UNKNOWN
-
Autocorrelated Rhythmic Auditory Stimulations for Parkinson's Disease Patients
NCT03716674 ·Status: COMPLETED ·Phase: NA
-
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
NCT02034357 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Oculomotor Training in Parkinson's Disease
NCT04560504 ·Status: COMPLETED ·Phase: NA
-
PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
NCT02035761 ·Status: COMPLETED